... biotechnology company developing novel immunotherapies to ... San Antonio Breast Cancer Symposium (SABCS®) taking place December 9-12 ...
News
- BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
- Lilly to highlight progress across key programs in early and advanced hormone receptor ...
... San Antonio Breast Cancer Symposium (SABCS), taking place December 9–12 ... Harnessing the power of biotechnology, chemistry and genetic ...
- UT Health San Antonio scientists launch innovative therapy study to help Parkinson's ...
... San Antonio, will lead a phase 2, multisite clinical trial to test a ... biomedical sciences and public health that are leading change and ...
- Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical ... - Nasdaq
Arvinas, Inc., a clinical-stage biotechnology ... San Antonio Breast Cancer Symposium, taking place December 9– 12, 2025 in San Antonio, Texas.
- Lilly to highlight progress across key programs in early and advanced hormone receptor ...
Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast ...